文献速递主动脉疾病

胸主动脉腔内修复术后B型主动脉夹层的动脉瘤样退变:系统综述

Aneurysmal degeneration of type B aortic dissections after thoracic endovascular aortic repair: A systematic review.
PubMed 文献 · J Vasc Surg · 2017-07-21

本系统综述评估了TEVAR治疗B型主动脉夹层后中远期主动脉扩张与动脉瘤样退变的发生情况。纳入17项研究显示,TEVAR后胸主动脉扩张发生率为6.6%至84%,腹主动脉扩张为10%至54%,慢性和急性夹层患者均有显著比例出现动脉瘤样退变。结论认为TEVAR不能阻止胸主动脉或腹主动脉的动脉瘤样退变,以预防退变为目的治疗无并发症患者与现有数据相悖。

要点

  • TEVAR后胸主动脉扩张发生率6.6%–84%,腹主动脉扩张10%–54%。
  • 慢性和急性夹层患者接受TEVAR后均有显著比例发生动脉瘤样退变。
  • TEVAR不能阻止胸主动脉或腹主动脉的动脉瘤样退变。

核心结论

  • 基于现有数据,TEVAR治疗B型主动脉夹层不能阻止胸主动脉或腹主动脉的动脉瘤样退变。
  • 以预防动脉瘤样退变为目的治疗无并发症的B型主动脉夹层患者,目前与现有数据相悖。

研究设计与样本

  • 系统综述,检索评估TEVAR治疗B型主动脉夹层后中长期结局的研究。
  • 纳入标准为记录了主动脉体积或直径变化的研究,排除仅记录研究人群平均主动脉直径变化的文献。
  • 最终纳入17项评估胸主动脉扩张的研究,其中6项同时评估了腹主动脉扩张。

主要发现

  • TEVAR后胸主动脉扩张在各项研究中的发生率为6.6%至84%。
  • TEVAR后腹主动脉扩张在6项研究中的发生率为10%至54%。
  • 按慢性期分层,慢性和急性夹层患者接受TEVAR后均有显著比例出现动脉瘤样退变。

临床怎么用

  • TEVAR术后需对胸主动脉和腹主动脉的扩张进行长期影像学监测。
  • 不应仅以预防动脉瘤样退变为目的对无并发症的B型主动脉夹层患者行TEVAR。

局限性

  • B型主动脉夹层文献报告方式存在差异,需建立报告标准以统一数据并加深对该复杂疾病过程的理解。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Promising results of thoracic endovascular aortic repair (TEVAR) in patients with complicated type B aortic dissection (TBAD) have been well documented. However, whereas early results have led many to hypothesize a benefit of TEVAR in uncomplicated patients, the natural history of TEVAR after the treatment of TBAD has yet to mature. In this review, we evaluated the available data to investigate whether longer term TEVAR warrants enthusiasm for all comers with TBAD. METHODS: A systematic review of the literature was performed searching specifically for studies assessing medium- and long-term outcomes after TEVAR for the treatment of TBAD. Studies were included if changes in aortic volume or diameter were recorded. Any publications recording only changes in mean aortic diameter across the study population were excluded. RESULTS: A total of 17 studies examining growth in the thoracic aorta were included. This event occurred in 6.6% to 84% of patients across studies. Six studies examined growth in the abdominal aorta after TEVAR, which occurred in 10% to 54% of patients. When viewed by chronicity, a significant number of patients treated for chronic and acute dissection experienced aneurysmal degeneration. CONCLUSIONS: Based on the available data to date, TEVAR for TBAD does not prevent aneurysmal degeneration of the thoracic or abdominal aorta. Therefore, the treatment of uncomplicated patients with this goal in mind is currently contrary to the available data. Given the variability of manuscript reporting styles for TBAD, the development of reporting standards is necessary to homogenize available data and to strengthen our understanding of this complex disease process.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Famularo M, Meyermann K, Lombardi JV, et al. Aneurysmal degeneration of type B aortic dissections after thoracic endovascular aortic repair: A systematic review. J Vasc Surg. 2017. PMID: 28736120. doi:10.1016/j.jvs.2017.06.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。